Abbott Laboratories 8-K Filing
Ticker: ABT · Form: 8-K · Filed: Nov 21, 2025 · CIK: 1800
| Field | Detail |
|---|---|
| Company | Abbott Laboratories (ABT) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Abbott Laboratories (ticker: ABT) to the SEC on Nov 21, 2025.
How long is this filing?
Abbott Laboratories's 8-K filing is 2 pages with approximately 719 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 719 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2025-11-21 16:06:09
Filing Documents
- tm2531676d1_8k.htm (8-K) — 31KB
- tm2531676d1_ex99-1.htm (EX-99.1) — 5KB
- 0001104659-25-114995.txt ( ) — 249KB
- abt-20251118.xsd (EX-101.SCH) — 3KB
- abt-20251118_def.xml (EX-101.DEF) — 28KB
- abt-20251118_lab.xml (EX-101.LAB) — 37KB
- abt-20251118_pre.xml (EX-101.PRE) — 26KB
- tm2531676d1_8k_htm.xml (XML) — 5KB
04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
Item 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans On November 18, 2025, Abbott Laboratories ("Abbott") received a notice from the plan administrator of the Abbott Laboratories Stock Retirement Plan ("U.S. Plan") and the Abbott Laboratories Stock Retirement Plan (Puerto Rico) ("P.R. Plan"; collectively, the "Plans") pursuant to Section 101(i)(2)(E) of the Employee Retirement Income Security Act of 1974 regarding a blackout period (the "Blackout Period") under the Plans. The Blackout Period is required because the Plans are making certain administrative changes, including changing the recordkeeper, changing the trustee for certain funds of the U.S. Plan, and changing the custodian of certain funds of the P.R. Plan. During the Blackout Period, Plan participants will be unable to engage in transactions involving the assets held in their Plan accounts, including changing contribution rates, directing or diversifying investments (including investments in Abbott common shares), or obtaining a Plan loan, withdrawal, or distribution. As described more fully in the Notice (as defined below), the Blackout Period is expected to begin on December 24, 2025 at 12 p.m. CST and expected to end during the week of January 11, 2026. During the Blackout Period and for two years after the ending date of the Blackout Period, a security holder or other interested person may obtain, without charge, information regarding the Blackout Period, including the actual beginning and ending dates of the Blackout Period, by submitting a request to Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, Attn: Divisional Vice President, Compensation and Benefits; (224) 667-6100. On November 21, 2025, Abbott sent a notice to its directors and executive officers (the "Notice") informing them of the Blackout Period and the restrictions on trading in Abbott common shares that apply to them during the Blackout Period, pursuant to Section 306 of the Sarb
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits Exhibit No. Exhibit 99.1 Notice provided to directors and executive officers of Abbott Laboratories on November 21, 2025. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABBOTT LABORATORIES Date: November 21, 2025 By: /s/ Philip P. Boudreau Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer